Shares of other companies:
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Tesla Q1: Model 2 Could Be Their Model T
April 25, 2024
Tesla Is An AI Company That The Market Won’t Reward For Now
April 24, 2024
Amazon: The Margin Train Is Gaining Speed
April 24, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
MESO Stock News and Mentions of Mesoblast Limited Stocktwits
Updated: April 28, 2024 (09:14)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Mesoblast Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Mesoblast Limited (MESO).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Mesoblast stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Mesoblast Limited (MESO)
April 23, 2024 (14:50) / "Benzinga" (by Avi Kapoor)
HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday - BeiGene ( NASDAQ:BGNE ) , Bloom Energy ( NYSE:BE )
U.S. stocks were higher, with the Nasdaq Composite gaining over 200 points on Tuesday. Shares of HealthStream, Inc. HSTM rose sharply during Tuesday's session following upbeat quarterly results. HealthStream posted first-quarter GAAP earnings of 17 cents per share, beating market estimates of 11 ...
In Article Trend: Somewhat-Bullish
April 17, 2024 (14:55) / "Benzinga" (by Avi Kapoor)
United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday - United Airlines Holdings ( NASDAQ:UAL )
U.S. stocks were lower, with the Dow Jones index falling over 50 points on Wednesday. Shares of United Airlines Holdings, Inc. UAL rose sharply during Wednesday's session after the company reported better-than-expected first-quarter financial results. Revenue of $12.539 billion topped estimates ...
In Article Trend: Neutral
April 9, 2024 (21:41) / "PR Newswire" (by DelveInsight Business Research)
Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight
The tissue banking market is experiencing a surge in demand due to several factors: the growing prevalence and occurrence of chronic illnesses, the expanding elderly population susceptible to such ailments, and the potential breakthroughs in treating cancers, blood disorders, immune conditions, ...
In Article Trend: Somewhat-Bullish
April 8, 2024 (21:31) / "PR Newswire" (by DelveInsight Business Research)
Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsight
The growth of the giant-cell arteritis market is expected to be mainly driven by the growing geriatric population, the rise in the prevalence of cardiovascular disorders, technological advancements in the healthcare industry, and others.
In Article Trend: Somewhat-Bullish
April 8, 2024 (14:17) / "Benzinga" (by Avi Kapoor)
Model N, Ducommun, Perpetua Resources And Other Big Stocks Moving Higher On Monday - Ducommun ( NYSE:DCO ) , Model N ( NYSE:MODN )
U.S. stocks were mostly higher, with the Nasdaq Composite gaining around 0.1% on Monday. Shares of Model N, Inc. MODN rose sharply during Monday's session after the company announced it will be acquired by Vista Equity Partners for $1.25 billion. Model N shares jumped 10.7% to $30.00 on Monday.
In Article Trend: Somewhat-Bullish
April 3, 2024 (12:43) / "Business Insider" (by Avi Kapoor)
Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Why Cal-Maine Foods Shares Are Trading Higher By Around 8%. Here Are 20 Stocks Moving Premarket - Markets Insider ...
In Article Trend: Somewhat-Bullish
April 3, 2024 (12:10) / "Benzinga" (by Avi Kapoor)
Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Cal-Maine Foods ( NASDAQ:CALM )
Shares of Cal-Maine Foods, Inc. CALM rose sharply in today's pre-market trading after the company reported upbeat results for its fourth quarter. The company reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $2.46 per share, according to data from ...
In Article Trend: Somewhat-Bullish
April 3, 2024 (10:14) / "Business Insider" (by Avi Kapoor)
Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were lower this morning, with the Nasdaq futures falling by around 0.2% on Wednesday. Shares of Intel Corporation ( NASDAQ:INTC ) fell sharply in today's pre-market trading after the company outlined a new financial framework for its foundry business.
In Article Trend: Neutral
April 3, 2024 (09:36) / "Benzinga" (by Avi Kapoor)
Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Intel ( NASDAQ:INTC )
U.S. stock futures were lower this morning, with the Nasdaq futures falling by around 0.2% on Wednesday. Shares of Intel Corporation INTC fell sharply in today's pre-market trading after the company outlined a new financial framework for its foundry business.
In Article Trend: Neutral
April 3, 2024 (07:22) / "Stocknews.com" (by Defense World Staff)
Mesoblast ( NASDAQ:MESO ) Downgraded to "Sell" at StockNews.com
StockNews.com downgraded shares of Mesoblast ( NASDAQ:MESO - Free Report ) from a hold rating to a sell rating in a research note published on Tuesday morning. Separately, Cantor Fitzgerald restated an overweight rating on shares of Mesoblast in a research note on Friday, January 12th.
In Article Trend: Somewhat-Bullish
April 1, 2024 (17:12) / "Business Insider" (by Avi Kapoor)
Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday. Shares of Micron Technology, Inc. ( NASDAQ:MU ) rose sharply during Monday's session after B of A Securities maintained a Buy rating on the stock and raised its price target from $120 to $144.
In Article Trend: Neutral
April 1, 2024 (17:02) / "Benzinga" (by Avi Kapoor)
Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday - Micron Technology ( NASDAQ:MU ) , Trip.com Group ( NASDAQ:TCOM )
U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday. Shares of Micron Technology, Inc. MU rose sharply during Monday's session after B of A Securities maintained a Buy rating on the stock and raised its price target from $120 to $144.
In Article Trend: Somewhat-Bullish
March 28, 2024 (12:30) / "Benzinga" (by Avi Kapoor)
Top 5 Health Care Stocks That May Plunge In March - Mesoblast ( NASDAQ:MESO ) , Inozyme Pharma ( NASDAQ:INZY )
As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when ...
In Article Trend: Somewhat-Bullish
March 27, 2024 (15:00) / "Zacks Commentary" (by Zacks Equity Research)
Mesoblast ( MESO ) to File Pediatric GVHD Drug BLA, Stock Up
Mesoblast (MESO) gains as the FDA states that the available phase III data for lead candidate, remestemcel-L, is sufficient to support a regulatory filing for pediatric SR-aGVHD indication.
In Article Trend: Neutral
March 27, 2024 (12:14) / "Benzinga" (by Avi Kapoor)
Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket - MariaDB ( NYSE:MRDB )
Shares of MariaDB plc MRDB rose sharply in today's pre-market trading after Progress Software PRGS announced that it is possibly considering an offer for the company. MariaDB shares jumped 100.4% to $0.4530 in pre-market trading Here are some other stocks moving in pre-market trading.
In Article Trend: Somewhat-Bullish
March 27, 2024 (09:39) / "Benzinga" (by Avi Kapoor)
GameStop Posts Downbeat Results, Joins Direct Digital, Forge Global And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - GameStop ( NYSE:GME ) , Direct Digital Holdings ( NASDAQ:DRCT )
U.S. stock futures were higher this morning, with the Dow futures gaining by more than 100 points on Wednesday. Shares of GameStop Corp. GME fell sharply in today's pre-market trading as the company posted weaker-than-expected results for its fourth quarter on Tuesday.
In Article Trend: Neutral
March 26, 2024 (19:08) / "Benzinga" (by Avi Kapoor)
Crude Oil Moves Lower; TD SYNNEX Earnings Top Estimates - Cardlytics ( NASDAQ:CDLX ) , AppTech Payments ( NASDAQ:APCX )
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 80 points on Tuesday. The Dow traded up 0.21% to 39,397.20 while the NASDAQ rose 0.23% to 16,421.62. The S&P 500 also rose, gaining, 0.17% to 5,227.03. Consumer discretionary shares jumped by 0.6% on Monday.
In Article Trend: Somewhat-Bullish
March 26, 2024 (16:47) / "Benzinga" (by Vandana Singh)
Why Is Mesoblast Stock Trading Higher On Tuesday? - Mesoblast ( NASDAQ:MESO )
Monday, the FDA informed Mesoblast Limited MESO that following additional consideration, the available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission of the proposed Biologics License Application ( BLA ) for remestemcel-L for pediatric patients with ...
In Article Trend: Somewhat-Bullish
March 26, 2024 (16:08) / "Benzinga" (by Avi Kapoor)
Dow Gains 100 Points; McCormick Posts Upbeat Results - Cardlytics ( NASDAQ:CDLX ) , AppTech Payments ( NASDAQ:APCX )
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 100 points on Tuesday. The Dow traded up 0.25% to 39,413.30 while the NASDAQ rose 0.27% to 16,448.55. The S&P 500 also rose, gaining, 0.27% to 5,232.36. Consumer discretionary shares jumped by 0.8% on Monday.
In Article Trend: Somewhat-Bullish
March 26, 2024 (12:00) / "Benzinga" (by Avi Kapoor)
Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket - Stoke Therapeutics ( NASDAQ:STOK )
Shares of Stoke Therapeutics, Inc. STOK rose sharply in today's pre-market trading after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome. Stoke Therapeutics shares jumped 69.7% to $11.03 in pre-market trading Here are some other stocks moving in ...
In Article Trend: Neutral
March 26, 2024 (02:34) / "GlobeNewswire" (by Mesoblast Limited)
United States Food & Drug Administration ( FDA ) Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease ( SR-aGVHD )
NEW YORK, March 25, 2024 ( GLOBE NEWSWIRE ) -- Mesoblast Limited ( Nasdaq:MESO. ASX:MSB ) , global leader in allogeneic cellular medicines for inflammatory diseases, today announced that U.S. FDA has informed the company that following additional consideration the available clinical data from its ...
In Article Trend: Neutral
March 13, 2024 (23:30) / "GlobeNewswire" (by Mesoblast Limited)
Mesoblast Successfully Completes Placement and Accelerated Entitlement Offer
NEW YORK, March 13, 2024 ( GLOBE NEWSWIRE ) -- Mesoblast Limited ( Nasdaq:MESO. ASX:MSB ) , global leader in allogeneic cellular medicines for inflammatory diseases, today announced it has received firm commitments to complete its pro-rata accelerated non-renounceable entitlement offer that was ...
In Article Trend: Neutral
March 11, 2024 (13:24) / "Benzinga" (by Vandana Singh)
Why Is Mesoblast Stock Trading Higher On Monday? - Mesoblast ( NASDAQ:MESO )
Monday, Mesoblast Limited MESO announced that the FDA supports an accelerated approval pathway for rexlemestrocel-L, its allogeneic mesenchymal precursor cell product, for end-stage ischemic heart failure with reduced ejection fraction ( HFrEF ) and a left ventricular assist device ( LVAD ) .
In Article Trend: Neutral
March 11, 2024 (12:08) / "Benzinga" (by Avi Kapoor)
Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket - Avenue Therapeutics ( NASDAQ:ATXI ) , Auddia ( NASDAQ:AUUD )
Shares of Fangdd Network Group Ltd. DUO rose sharply in today's pre-market trading after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services sector. Fangdd Network Group shares jumped 78.3% to $1.08 in pre-market trading
In Article Trend: Neutral
March 10, 2024 (23:54) / "GlobeNewswire" (by Mesoblast Limited)
United States Food & Drug Administration ( FDA ) Supports Accelerated Approval Pathway for Rexlemestrocel-L in End-Stage Heart Failure Patients with a Left Ventricular Assist Device ( LVAD )
NEW YORK, March 10, 2024 ( GLOBE NEWSWIRE ) -- Mesoblast Limited ( Nasdaq:MESO. ASX:MSB ) , global leader in allogeneic cellular medicines for inflammatory diseases, today announced that U.S. FDA supports an accelerated approval pathway for rexlemestrocel-L, Mesoblast's allogeneic mesenchymal ...
In Article Trend: Neutral
March 6, 2024 (06:50) / "Stocknews.com" (by Defense World Staff)
Mesoblast ( NASDAQ:MESO ) Rating Increased to Hold at StockNews.com
Mesoblast ( NASDAQ:MESO - Get Free Report ) was upgraded by StockNews.com from a "sell" rating to a "hold" rating in a report released on Monday. Separately, Cantor Fitzgerald restated an "overweight" rating on shares of Mesoblast in a research note on Friday, January 12th.
In Article Trend: Somewhat-Bullish
February 28, 2024 (22:57) / "GlobeNewswire" (by Mesoblast Limited)
Mesoblast Reports Financial Results and Operational Update for Half-Year Ended December 31, 2023
NEW YORK, Feb. 28, 2024 ( GLOBE NEWSWIRE ) -- Mesoblast Limited ( Nasdaq:MESO. ASX:MSB ) , global leader in allogeneic cellular medicines for inflammatory diseases, today provided an operational update and reported financial results for the period ended December 31, 2023.
In Article Trend: Neutral
Related stocks from Healthcare sector
ImmunityBio, Inc. (IBRX)
Hologic, Inc. (HOLX)
Kura Oncology, Inc. (KURA)
Invitae Corp. (NVTA)
Becton Dickinson and Company (BDX)
Vaccinex, Inc. (VCNX)
Bristol-Myers Squibb Company (BMY)
BioDelivery Sciences International, Inc. (BDSI)
BeyondSpring Inc. (BYSI)
China Evergrande New Energy Vehicle Group Lim. (EVGRF)
This website uses cookies to ensure you get the best experience on our website